Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Earnings release
confidence 98%
filed 2026-10-22
Item 2.02
Kinsale Capital Group issued a press release on October 22, 2026 announcing its financial results for the three and nine months ended September 30, 2026. The disclosure includes detailed quarterly and year-to-date net income ($98.1 million and $386.6 million respectively), diluted earnings per share ($4.36 and $16.97), underwriting income, combined ratios, and other key financial metrics. This is a standard earnings release disclosure under Item 2.02, material to investors assessing the company's financial performance and profitability.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-10-22
Item 5.02
Christopher R. Tangard was appointed to the position of Executive Vice President, Chief Financial Officer and Treasurer, effective March 2, 2027, succeeding Bryan P. Petrucelli.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-10-22
Item 2.02
FVCBankcorp issued a press release on October 22, 2026 reporting quarterly and nine-month financial results for the period ended September 30, 2026, including net income of $6.6 million for Q3 2026 (19% increase year-over-year) and nine-month net income of $21.2 million (29% increase year-over-year), along with diluted EPS of $0.37 and comprehensive financial metrics.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-10-22
Item 7.01
Unusual Machines announced receipt of a $16.9 million purchase order from Powerus Corporation for drone components. This is a material commercial contract/order that represents significant revenue opportunity and demonstrates business traction with a strategic customer, but does not fit the specific categories of M&A, debt issuance, earnings release, or other named event types. The order is material to investors as it evidences operational momentum and customer demand, particularly given the company's focus on NDAA-compliant drone components for the U.S. defense market.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 94%
filed 2026-10-22
Item 1.01
CitroTech entered into an underwriting agreement on October 21, 2026, for a registered public offering of 2,240,000 shares at $2.50 per share, generating approximately $5.6 million in gross proceeds, with a 45-day underwriter option for an additional 336,000 shares. The offering materially dilutes existing shareholders and affects the company's capital structure.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-10-22
Item 1.01
The filing discloses entry into bridge note agreements and amendments thereto as interim financing for target companies pending a material merger. While Item 1.01 nominally covers "Entry into a Material Definitive Agreement," the substance here is the bridge financing supporting a previously disclosed merger transaction (Merger Agreement dated February 17, 2026) under which Auddia and three target companies would become subsidiaries of McCarthy Finney, a publicly traded holding company. The bridge notes are integral to the pending merger activity and represent material financial commitments ($3.305 million aggregate after amendment) by Auddia to the target companies. This is best classified as ma_activity because the bridge notes are financing mechanisms directly tied to the contemplated merger and change of control.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-10-22
Item 7.01
The filing discloses a declaration of distributions by Nuveen Global Cities REIT to holders of each class of common stock on October 22, 2026, with specific per-share amounts (ranging from $0.04355114 to $0.05647554 net per share depending on class) payable on or about that date. This is a routine but material dividend/distribution declaration typical of REITs, which are required to distribute substantially all taxable income to shareholders. The disclosure includes gross distributions, fees, and net amounts payable to stockholders of record.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-10-22
Item 3.02
The filing discloses multiple unregistered sales of equity securities totaling approximately $3.67 million across Class C, Class E, and Class I common shares issued to the Adviser, Brookfield affiliates, feeder vehicles, and employees during October 2026. These private placements under Section 4(a)(2) and Regulation S/D represent dilutive issuances that would materially affect investor assessment of share ownership and capital structure, particularly given the significant volume and the involvement of the affiliated Adviser and Brookfield entities.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-10-22
Item 2.02
OP Bancorp issued a press release on October 22, 2026 announcing preliminary unaudited financial results for Q3 2026, including net income of $7.8 million and diluted EPS of $0.52, with detailed income statement, balance sheet, and credit quality metrics.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-10-22
Item 8.01
OP Bancorp's Board declared a quarterly cash dividend of $0.14 per share on common stock, payable November 19, 2026, to shareholders of record as of November 5, 2026.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-10-22
Item 5.02
The filing discloses the appointment of Ross Moat as President and Chief Operating Officer effective immediately on October 17, 2026. While the disclosure also includes compensation adjustments (salary increase from $650,000 to $700,000 and bonus target increase from 55% to 60%), the principal action is the promotion to a new executive title. The appointment of an officer to a senior C-suite role is material to investors assessing company leadership and governance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-10-22
Item 2.02
BayCom Corp disclosed its third quarter 2026 earnings results via press release attached as Exhibit 99.1, reporting net income of $1.1 million ($0.10 per diluted share) for Q3 2026. This is a standard quarterly earnings release disclosure under Item 2.02, with detailed financial performance metrics, net interest margin analysis, and management commentary on strategic actions taken during the quarter.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 97%
filed 2026-10-22
Item 3.01
Lunai Bioworks received a Nasdaq determination on October 21, 2026, that it no longer complies with Listing Rule 5550(b)(1) due to a stockholders' deficit of $(9,024,946), failing to meet minimum equity requirements. The Company's Board approved voluntary withdrawal from Nasdaq listing on October 22, 2026, with trading suspension expected October 30, 2026, and delisting effective November 12, 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-10-22
Item 2.02
Amerant Bancorp reported Q3 2026 financial results (quarter ended September 30, 2026) with net income of $25.7 million ($0.65 diluted EPS), including detailed financial metrics, balance sheet data, and asset quality indicators disclosed via press release and earnings presentation.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 92%
filed 2026-10-22
Item 8.01
The Board declared a cash dividend of $0.09 per share of Class A common stock payable November 27, 2026, and approved an extension and increase of the share repurchase program from $3 million to $50 million through December 31, 2027.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-10-22
Item 2.02
Dow Inc. issued a press release on October 22, 2026, announcing third quarter 2026 financial results, including net sales of $11.3 billion (up 13% YoY), GAAP net income of $525 million, and operating EPS of $0.71. The disclosure is a standard quarterly earnings announcement with detailed segment performance, cash flow metrics, and forward guidance, attached as Exhibit 99.1 and filed under Item 2.02 (Results of Operations and Financial Condition).
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-10-22
Item 8.01
The filing discloses a declaration of a regular quarterly cash dividend of $0.54 per share, payable December 18, 2026, to shareholders of record on December 8, 2026. The press release explicitly notes this represents a 2 percent increase from the prior dividend. This is a straightforward dividend distribution event material to shareholders and investors assessing capital allocation and shareholder returns.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-10-22
EX-99.1
This press release announces a clinical trial collaboration and supply agreement between BioNTech and Gilead Sciences to evaluate pumitamig in combination with sacituzumab govitecan in the ROSETTA Breast-01 Phase 3 trial for triple-negative breast cancer. The announcement describes an adaptation of an ongoing trial to reflect evolving standard of care and represents a material operational/strategic development in BioNTech's oncology pipeline, but does not constitute a discrete M&A transaction, earnings disclosure, executive change, or other specifically-named event type. The collaboration is material to investors as it reflects progress in a key late-stage development program and partnership strategy.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-10-22
Item 3.02
Blackstone Private Credit Fund completed an unregistered private placement of 726,099 Class I common shares for $17.07 million, exempt under Section 4(a)(2) and Regulation S, diluting existing shareholders.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-10-22
Item 7.01
The Fund declared regular distributions to shareholders across Class I, S, and D share classes, with specified per-share amounts, record dates, and payment dates.
View raw filing on EDGAR →
8-K
Financial Other
confidence 85%
filed 2026-10-22
Item 8.01
The Fund reported its net asset value per share of $23.51 as of September 30, 2026, aggregate NAV of $41.1 billion, portfolio fair value of $75.6 billion, debt outstanding of $34.8 billion, and disclosed leverage metrics and the status of ongoing public and private share offerings totaling $57.2 billion in consideration issued to date.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-10-22
Item 2.02
Amalgamated Financial Corp. announced record Q3 2026 financial results with net income of $36.4 million ($1.20 per diluted share) and core net income of $34.6 million ($1.14 per diluted share), along with record operating revenue of $101.7 million and comprehensive financial metrics. The earnings announcement was accompanied by a conference call and slide presentation.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-10-22
This is a press release announcing preliminary third-quarter 2026 financial results for Pharming Group N.V., disclosing total revenues of approximately US$117.6 million (21% year-over-year growth) and operating expenses of US$74.6 million, along with tightened full-year 2026 revenue guidance. The disclosure explicitly states "Pharming Group announces third quarter 2026 revenues above market expectations" and provides preliminary unaudited revenue and select financial information for the three months ended September 30, 2026, which is the hallmark of an earnings release.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-10-22
Item 7.01
This 8-K discloses a material clarification and correction of unauthorized third-party reporting about the Company's 2027 revenue guidance and customer shipments. The Company explicitly disavows the $100 million 2027 revenue estimate published in The Electric article, clarifies that shipments were to a smart eyewear customer (not smartphone maker) and were 17,000 cells (not 50,000), and defers official guidance to November 12, 2026. While the disclosure corrects misinformation rather than announcing a primary corporate event, the correction of material forward-looking statements and customer information would affect a reasonable investor's assessment of the Company's business prospects and pipeline.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-10-22
Item 5.02
Roderick McIllree resigned from his position as a member of the Board of Directors of Greenland Energy Company effective immediately on October 20, 2026, and ceased serving in all other roles with the Company.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-10-22
Item 3.02
CXApp issued 214,072 shares of Common Stock to Avondale Capital, LLC between August 24 and October 21, 2026 under a Pre-Paid Purchase agreement at prices ranging from $1.74 to $4.35 per share, relying on Section 4(a)(2) of the Securities Act for unregistered sales. The company simultaneously entered into a Standstill Agreement with Avondale that restricts but does not eliminate Avondale's ability to exercise pre-paid purchase rights to convert outstanding financing instruments into common stock, with the agreement explicitly contemplating resumption of purchases upon termination that could result in additional share issuances and dilution to existing stockholders.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 75%
filed 2026-10-22
Item 8.01
The Board of Directors authorized a $1 million share repurchase program, representing a return of capital to shareholders and reflecting Board confidence in the company's long-term prospects and disciplined capital management.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-10-22
Item 5.02
Timothy Smith, Chief Commercial Officer of Lineage, Inc., has notified the Company of his planned retirement effective April 19, 2027. This is a clear executive departure disclosure under Item 5.02, as the principal action is a named officer leaving his role. The CCO position is material to investor assessment of the company's commercial strategy and leadership continuity.
View raw filing on EDGAR →
8-K
Operational Other
confidence 72%
filed 2026-10-22
Item 8.01
The Item 8.01 disclosure comprises three press releases (October 20, 21, 22, 2026) announcing strategic initiatives and business developments. The October 20 letter outlines a "predictive intelligence" strategy and path forward, addressing shareholder concerns about Nasdaq compliance and future direction. The October 21 release announces $383,000 in new Digital Ally contracts. These are operational and strategic announcements—not earnings results, M&A, executive changes, or other specifically-defined event types—that communicate management's vision and near-term business developments to shareholders. While material to investor assessment of the company's direction and prospects, they do not fit neatly into the taxonomy's specific categories and are best classified as operational_other.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-10-22
Item 3.03
Blaize announced a distribution of Series B Preferred Stock to common shareholders with voting rights tied exclusively to a potential reverse stock split proposal. The distribution creates a new preferred class with limited, conditional voting power designed to facilitate shareholder voting on a reverse stock split, representing a material modification to the capital structure and voting rights of security holders.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-10-22
EX-99.1
This is a press release announcing Q3 2026 and nine-month 2026 unaudited revenues for Ermenegildo Zegna N.V., dated October 22, 2026. The document discloses detailed financial results including total revenues of €433.8 million for Q3 2026 (+8.9% YoY) and €1,421.1 million for 9M 2026 (+7.2% YoY), broken down by brand, channel, and geography. This is a discrete earnings announcement, not a periodic financial report, and would materially affect a reasonable investor's assessment of the company's financial performance and growth trajectory.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-10-22
Item 8.01
The filing discloses notice of redemption of $25 million in 5.75% Fixed-to-Floating Rate Subordinated Notes due December 1, 2029, with redemption scheduled for December 1, 2026 at par plus accrued interest. While this is technically a debt retirement rather than issuance, it represents a material modification or termination of an existing direct financial obligation. The most appropriate classification is debt_issuance as the closest fit for material debt-related events, though the confidence is moderate because the taxonomy does not have a dedicated "debt_retirement" or "debt_redemption" category.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-10-22
Item 3.02
Blackstone Private Equity Strategies Fund L.P. and its feeder fund completed unregistered sales of limited partnership units totaling approximately $545.4 million in aggregate consideration to accredited investors and qualified purchasers under Section 4(a)(2) and Regulation D exemptions. This private placement represents a material capital-raising and dilutive equity issuance event for the funds.
View raw filing on EDGAR →
8-K
Financial Other
confidence 85%
filed 2026-10-22
Item 7.01
The filing reports Transactional NAV per Unit for Blackstone Private Equity Strategies Fund L.P. and its feeder fund as of September 30, 2026, with aggregate fund NAV of approximately $19.9 billion and $28.5 billion respectively. This material financial disclosure provides unit pricing information relevant to investors in these funds.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-10-22
Item 7.01
Biohaven disclosed that the FDA has accepted its NDA resubmission for Vyglxia (troriluzole) in SCA for review and assigned a Q1 2027 user fee goal date, with an advisory committee meeting planned. This is a material regulatory milestone in the drug development process that would affect investor assessment of the company's pipeline progress and approval prospects, but it does not fit the specific categories of earnings release, M&A, impairment, litigation, or other defined event types. It is clearly operational/strategic in nature.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-10-22
Item 2.02
Burke & Herbert Financial Services Corp. issued a press release on October 22, 2026, announcing third quarter 2026 results of operations and financial condition, disclosing net income of $36.2 million and diluted EPS of $1.78, along with key financial metrics and consolidated financial statements.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-10-22
Item 8.01
Burke & Herbert's Board declared a regular quarterly cash dividend of $0.55 per share, payable December 1, 2026.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-10-22
EX-99.1
This exhibit is a Q3 2026 earnings results announcement for Vesta Real Estate Corporation. The document discloses quarterly financial results including total rental revenue (US$ 79.6 million), Adjusted NOI (US$ 72.9 million), Adjusted EBITDA (US$ 65.2 million), and Vesta FFO (US$ 47.1 million), along with revised full-year 2026 guidance for revenue growth (11.5%-12.5%) and margin improvements. The announcement includes a CEO letter, detailed financial tables, and operational highlights, all characteristic of a quarterly earnings release. Material to investors as it provides current financial performance and updated forward guidance.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-10-22
EX-99.1
LPA announces the launch of a US$85 million logistics development project (Parque Logístico Panamericana Sur) in Peru with institutional investors under its new capital-light model. This is a material operational and strategic event—a significant new development initiative representing the company's shift in business model and reinvestment strategy following asset monetizations. While it involves capital deployment and partnership, it is fundamentally an operational/strategic business announcement rather than a discrete M&A transaction, financing event, or earnings disclosure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-10-22
Item 3.02
Blackstone Infrastructure Strategies L.P. and its feeder fund completed unregistered sales of approximately $412.5 million in aggregate consideration of new limited partnership units on October 1, 2026, to accredited investors and qualified purchasers pursuant to Section 4(a)(2) and Regulation D exemptions.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 92%
filed 2026-10-22
Item 7.01
Blackstone Infrastructure Strategies L.P. declared regular distributions to unitholders with per-unit amounts ranging from $0.2266 to $0.2289 across multiple unit classes, payable on or about November 3, 2026.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-10-22
Item 1.01
ContextLogic amended its Stock Purchase Agreement for an $850 million acquisition of the Target Company, modifying the rollover equity component from $2.0 million to $7.0 million, representing a material modification to the transaction structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-10-22
Item 8.01
ContextLogic announced plans to conduct a rights offering to existing shareholders, with terms to be described in a registration statement and prospectus and expected closing in late 2026 or Q1 2027.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-10-22
Item 3.02
Blackstone Multi-Strategy Hedge Fund L.P. sold approximately $106.5 million in unregistered limited partnership units to accredited investors and qualified purchasers on October 1, 2026, under Section 4(a)(2) and Regulation D exemptions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-10-21
Item 5.07
This is a classic Item 5.07 disclosure reporting the final results of CACI's Annual Meeting of Shareholders held on October 15, 2026. The filing presents voting tallies for three proposals: election of ten directors, advisory approval of named executive officer compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor. All three proposals passed with substantial majorities, and the detailed vote counts (For, Against, Abstain, Broker Non-Votes) are the core content of the disclosure.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-10-21
Item 2.02
This Item 2.02 disclosure furnishes a press release announcing EastGroup's third quarter 2026 financial results, including diluted EPS of $1.46 (vs. $1.26 prior year), FFO of $2.45 per share (up 7.9%), and same-property NOI growth of 5.3% to 7.1%. The filing explicitly states that a press release relating to results of operations for the quarter ended September 30, 2026 is attached as Exhibit 99.1, which is the standard format for an earnings release disclosure under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-10-21
Item 2.02
IBM disclosed third-quarter 2026 financial results via press release dated October 21, 2026, including consolidated financial statements for the period ended September 30, 2026. The disclosure covers revenue ($17.1B, up 5%), net income ($2.2B, up 26%), diluted EPS ($2.31, up 26%), and segment performance across Software, Consulting, Infrastructure, and Financing. This is a standard quarterly earnings release with full income statement, balance sheet, and cash flow statements, clearly falling under Item 2.02 (Results of Operations and Financial Condition).
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-21
Item 5.02
Jeffrey M. Stutz was appointed as Chief Executive Officer and Board member, effective October 21, 2026, following his service as Interim CEO since June 2026. The appointment includes compensatory arrangements comprising a base salary of $1,000,000, equity grants, and severance terms.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-21
Item 5.02
Bank of America's Board appointed two seasoned executives—James Fitterling (former CEO of Dow Inc.) and William Thomas (former Global CEO of KPMG International)—as directors effective immediately, expanding the Board from 12 to 14 members. The disclosure centers on the appointment action itself, with committee assignments and compensation details following. This is a material governance event affecting board composition at a major financial institution.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-10-21
Item 2.02
Northern Trust Corporation disclosed third-quarter 2026 financial results, reporting net income of $642.9 million and diluted earnings per share of $3.40, with comprehensive financial summaries, segment results, and management commentary.
View raw filing on EDGAR →